M. Fabbri

518 total citations
12 papers, 387 citations indexed

About

M. Fabbri is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, M. Fabbri has authored 12 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in M. Fabbri's work include Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). M. Fabbri is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). M. Fabbri collaborates with scholars based in Italy and United States. M. Fabbri's co-authors include Riccardo Ghidoni, Marco Trinchera, Lorenzo Fumagalli, Ruggero Pardi, Elisabetta Bianchi, Daniela Terribile, Stefano Magno, Federica Chiesa, Riccardo Masetti and Gianluca Franceschini and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and European Journal of Cancer.

In The Last Decade

M. Fabbri

12 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fabbri Italy 8 147 99 87 76 75 12 387
Sara Droetto Italy 11 278 1.9× 124 1.3× 131 1.5× 33 0.4× 40 0.5× 11 492
Thomas J. Lawley United States 8 222 1.5× 130 1.3× 56 0.6× 67 0.9× 159 2.1× 9 446
Adriana Haimovitz Israel 7 164 1.1× 126 1.3× 63 0.7× 43 0.6× 54 0.7× 11 395
Robert L. Hills United States 9 111 0.8× 40 0.4× 34 0.4× 122 1.6× 86 1.1× 9 396
I‐Hua Liu United States 9 216 1.5× 44 0.4× 84 1.0× 53 0.7× 44 0.6× 13 357
Kimio Fujii Japan 10 128 0.9× 73 0.7× 77 0.9× 22 0.3× 68 0.9× 25 348
Sébastien Mongrain Canada 6 228 1.6× 39 0.4× 79 0.9× 66 0.9× 28 0.4× 6 407
Yasufumi Niinaka United States 9 276 1.9× 61 0.6× 96 1.1× 126 1.7× 18 0.2× 10 510
Karen L. Singer United States 7 274 1.9× 166 1.7× 68 0.8× 43 0.6× 50 0.7× 7 527
Ute Ipe Germany 9 261 1.8× 135 1.4× 87 1.0× 41 0.5× 123 1.6× 10 461

Countries citing papers authored by M. Fabbri

Since Specialization
Citations

This map shows the geographic impact of M. Fabbri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fabbri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fabbri more than expected).

Fields of papers citing papers by M. Fabbri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fabbri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fabbri. The network helps show where M. Fabbri may publish in the future.

Co-authorship network of co-authors of M. Fabbri

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fabbri. A scholar is included among the top collaborators of M. Fabbri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fabbri. M. Fabbri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Roosbroeck, Katrien Van, Francesca Fanini, Tetsuro Setoyama, et al.. (2016). Targeting miR-155 to resensitize lung cancer to chemotherapy. European Journal of Cancer. 61. S116–S116. 2 indexed citations
2.
Franceschini, Gianluca, Daniela Terribile, Stefano Magno, et al.. (2008). Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.. European review for medical and pharmacological sciences. 11(5). 283–9. 3 indexed citations
3.
Masetti, Riccardo, Alba Di Leone, Gianluca Franceschini, et al.. (2006). Oncoplastic Techniques in the Conservative Surgical Treatment of Breast Cancer: An Overview. The Breast Journal. 12(s2). S174–S180. 69 indexed citations
4.
Ibrahim, Toni, M. Fabbri, Giovanni Luca Frassineti, et al.. (2003). Doxorubicin, Paclitaxel and Gemcitabine: a Phase I Study of a New Sequential Treatment in Stage III B - IV Breast Cancer. Journal of Chemotherapy. 15(5). 488–494. 5 indexed citations
5.
Fabbri, M.. (2003). T lymphocytes. The International Journal of Biochemistry & Cell Biology. 35(7). 1004–1008. 40 indexed citations
6.
Cavallaro, Antonio, et al.. (2003). [Diverticular disease: complications and treatment].. PubMed. 54(5). 693–8. 4 indexed citations
7.
Ridolfi, Laura, et al.. (2001). Intralesional granulocyte‐monocyte colony‐stimulating factor followed by subcutaneous interleukin‐2 in metastatic melanoma: a pilot study in elderly patients. Journal of the European Academy of Dermatology and Venereology. 15(3). 218–223. 27 indexed citations
9.
Fabbri, M., Elisabetta Bianchi, Lorenzo Fumagalli, & Ruggero Pardi. (1999). Regulation of lymphocyte traffic by adhesion molecules. Inflammation Research. 48(5). 239–246. 60 indexed citations
10.
Fabbri, M., Patrizia Castellani, Philip J. Gotwals, et al.. (1996). A functional monoclonal antibody recognizing the human alpha 1‐integrin I‐domain. Tissue Antigens. 48(1). 47–51. 25 indexed citations
11.
Mazzoni, Alessandra, Fabio Trave, M. Fabbri, Gaetano Leto, & Riccardo Ghidoni. (1992). Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.. PubMed. 11(6). 2181–5. 7 indexed citations
12.
Trinchera, Marco, M. Fabbri, & Riccardo Ghidoni. (1991). Topography of glycosyltransferases involved in the initial glycosylations of gangliosides.. Journal of Biological Chemistry. 266(31). 20907–20912. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026